Transrectal High-Intensity Focused Ultrasound

Tissue ablation of the PROSTATE performed by ultrasound from a transducer placed in the RECTUM. The procedure is used to treat prostate cancer (PROSTATIC NEOPLASMS) and benign prostatic hypertrophy (PROSTATIC HYPERPLASIA).

Also Known As:

Networked: 51 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Uchida, Toyoaki: 6 articles (01/2018 - 03/2002)
2.	Shoji, Sunao: 4 articles (01/2021 - 03/2006)
3.	Gelet, A: 4 articles (01/2020 - 08/2000)
4.	Gelet, Albert: 4 articles (12/2011 - 07/2005)
5.	Nakano, Mayura: 3 articles (01/2021 - 11/2009)
6.	Chapelon, Jean-Yves: 3 articles (12/2011 - 09/2007)
7.	Rouvière, Olivier: 3 articles (12/2011 - 09/2007)
8.	Hanada, Izumi: 2 articles (01/2021 - 01/2018)
9.	Miyajima, Akira: 2 articles (01/2021 - 01/2018)
10.	Nitta, Masahiro: 2 articles (01/2021 - 11/2009)

Related Diseases

1.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/01/1994 - "A 47% (+4.2 ml. per second) improvement in uroflowmetry and a 53% (-13.7 points) decrease in the American Urological Association symptom score 1 year after treatment clearly prove that transrectal high intensity focused ultrasound is a novel and safe minimally invasive treatment option for benign prostatic hyperplasia." 12/01/2007 - "To evaluate the safety and efficacy of transrectal high-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH), serial studies were conducted in 150 BPH patients before and 30 min, 1, 2, 6 and 12 month(s) after Sonablate-500 HIFU treatment. " 01/01/1996 - "The aim of this study was to determine the urodynamic impact of transrectal high-intensity focused ultrasound (HIFU), which is presently evaluated as a minimally invasive treatment option for benign prostatic hyperplasia (BPH), on bladder outflow obstruction by means of pressure flow analyses. " 08/01/2010 - "To explore the application of transrectal high-intensity focused ultrasound (HIFU) for treatment of benign prostatic hyperplasia (BPH). " 08/01/2010 - "[Transrectal high-intensity focused ultrasound for treatment of benign prostatic hyperplasia: report of 262 cases]."
2.	Prostatic Neoplasms (Prostate Cancer) 01/01/1999 - "We conducted a phase I/II study to evaluate the efficacy of transrectal high intensity focused ultrasound in the treatment of localized prostate cancer and to assess associated complications. " 01/01/2021 - "The objectives of the study is to evaluate the effects of focal therapy on urinary function in the anterior portion of the transition zone (TZ) with transrectal high-intensity focused ultrasound (HIFU) for localized prostate cancer (PCa). " 01/01/2024 - "Although long-term oncologic data remain limited, the authors describe several MR imaging-guided therapeutic options for the treatment of prostate cancer, including cryoablation, laser ablation, transrectal high-intensity focused ultrasound, and transurethral ultrasound ablation." 11/25/2023 - "The transurethral identification of the first thermal lesion generated by transrectal High Intensity Focused Ultrasound (HIFU) for the treatment of prostate cancer, was used to preliminarily test in silico the combined reconstruction method. " 04/01/2021 - "Following radiation biochemical failure, salvage transperineal cryotherapy (sCT, n=186), transrectal high intensity focused ultrasound ablation (sHIFU, n=113), or no salvage treatment (NST, identified from the pan-Canadian Prostate Cancer Risk Stratification [ProCaRS] database, n=982) were compared with propensity-score matching. "
3.	Lower Urinary Tract Symptoms 06/01/2000 - "The aim of this study was to determine the long-term outcome after transrectal high-intensity focused ultrasound (HIFU) therapy for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). " 06/01/2000 - "95 elderly men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) were assigned prospectively to the following five treatment arms; transurethral resection of the prostate (TURP; n = 28), transurethral electrovaporization (TUVP; n = 17), visual laser ablation of the prostate (VLAP; n = 17), transrectal high intensity focused ultrasound (HIFU; n = 20) and transurethral needle ablation (TUNA); n = 15). "
4.	Neoplasms (Cancer) 08/01/2008 - "Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound." 05/01/2007 - "With radiorecurrent cancer the potential radiation damage of the rectal wall renders transrectal high-intensity focused ultrasound more hazardous. " 01/01/2018 - "(Objective) To evaluate the efficacy and invasiveness of focal therapy with transrectal high-intensity focused ultrasound (HIFU) for localized prostate cancer based on spatial location of significant cancer with magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) fusion image-guided biopsy. "
5.	Residual Neoplasm 12/01/2011 - "Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer." 08/01/2008 - "To assess the role of magnetic resonance imaging (MRI) for evaluating changes in the prostate after transrectal high-intensity focused ultrasound (HIFU) for treating prostate cancer, correlating the findings with histology to assess its possible role in predicting the outcome, evaluating residual cancer or local recurrence of disease. "

Related Drugs and Biologics

1.	Prostate-Specific Antigen (Semenogelase)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Therapeutics
3.	Extracorporeal Shockwave Therapy
4.	Laser Therapy (Surgery, Laser)
5.	Salvage Therapy